Versant Ventures


Versant Ventures is a global venture capital firm that harnesses the power of science to deliver strong results. Since its inception in 1999, the firm has managed $5.5 billion in assets, facilitated over 50 IPOs, and executed more than 50 M&As. Versant Ventures is renowned for its experienced team, boasting over 100 years of venture capital experience, 60 years in pharma, and 45 years in biotech. The firm operates six locations and three discovery engines, maintaining over 30 academic partnerships to foster innovation and company creation in the biotechnology sector.

Versant Ventures

Versant Ventures


What We Do

Versant’s Discovery Engines consist of in-house teams of multi-disciplinary scientists working in state-of-the-art laboratory facilities to enable the launch of novel biotechnology companies with academic founders.


Portfolio

Closed $85 million Series B financing.

#Biotechnology

Announced $107 million Series B financing.

#Biotechnology

Launched with $50 million Series A financing.

#Biotechnology

Launched by Versant Ventures.

#Biotechnology

Disclosed $32.5 million financing.

#Biotechnology

Launched by Versant Ventures.

#Biotechnology